Total U.S. shipments of COVID-19 molecular diagnostic tests have reached 200 million, according to AdvaMed’s COVID-19 diagnostic supply registry. A breakdown of the data shows that diagnostics companies are shipping, on average, more than 1.4 million molecular tests each day.
“For the past few months, our diagnostics companies have made it clear they’ll do whatever it takes to stay ahead of COVID-19 testing demand to help bring this pandemic under control,” said Scott Whitaker, president and CEO of the medtech trade group. “Two hundred million molecular tests shipped nationwide since the beginning of the pandemic is a remarkable testament to their commitment to saving lives.”
Get the full story on our sister site, Medical Design & Outsourcing.